Survivin gene expression in chronic liver disease and hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 54, Issue 79, 2007, Pages 2040-2044

  Montorsi, Marco ^a   Maggioni, Marco ^a,b   Falleni, Monica ^a,b   Pellegrini, Caterina ^a,b   Donadon, Matteo ^a   Torzilli, Guido ^a   Santambrogio, Roberto ^c   Spinelli, Antonino ^a   Coggi, Guido ^a,b   Bosari, Silvano ^a,b,d  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d Division of Pathology   (Italy)

Author keywords

Hepatocellular carcinoma; Real time RT PCR; Survivin

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 37749037809     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ikeguchi M, Hirooka Y, Kaibara N: Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer 2002; 95(9):1938-1945.
2. Mise K, Tashiro S, Yogita S: Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinico-pathlogical factors and prognosis. Clin Cancer Res 1998; 4:1475-1482.
3. Tanaka D, Toh Y, Adachi E: Tumour progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 1993; 53:2884-2887.
4. Piao Z, Kim H, Jeon BK: Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer (Phila.) 1997; 80:865-872.
5. Ikeguchi M, Sato N, Hirooka Y: Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity. J Surg Oncol 1998; 68:225-230.
6. Ito Y, Matsuura N, Sakon M: Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma. Br J Cancer 1999; 81:747-751.
7. Tung-Ping Poon R, Fan ST, Wong J: Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 32:10-24.
8. Altieri DC: The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7:542-547.
9. Ito T, Shiraki K, Sugimoto K: Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 2000; 31:1080-1085.
10. Conway EM, Pollefeyt S, Steiner-Mosonyi M: Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 2002; 123(2):619-631.
11. Li F, Altieri DC: The cancer antiapoptosis mouse surviving gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res 1999; 59(13):3143-3151.
12. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3:917-921.
13. Adida C, Crotty PL, McGrath J: Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998; 152:43-49.
14. Fogt F, Poremba C, Shibao K: Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis. Appl Immunohistochem Molecul Morphol 2001; 9:143-149.
15. Gianani R, Jarboe E, Orlicky D: Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 2001; 32:119-125.
16. Kawasaki H, Toyoda M, Shinohara H: Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 2001; 91:2026-2032.
17. Lanham S, Herbert A, Watt P: HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients. J Clin Pathol 2001; 54:304-308.
18. Kim HS, Shiraki K, Park SH: Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 2002; 22:805-808.
19. Frost M, Jarboe EA, Orlinki D: Immunohistochemical localisation of surviving in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 2002; 117:738-744.
20. Sasaki T, Lopes MB, hankins GR: Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol (Berl) 2002; 104:105-109.
21. Lehner R, Lucia MS, Jarboe EA: Immunohistochemical localisation of the IAP protein surviving in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 2002; 10:134-138.
22. Lu CD, Altieri DC, Tanigawa N: Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998; 58:1808-1812.
23. Kawasaki H, Altieri DC, Lu CD: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998; 58:5071-5074.
24. Sarela AI, Scott N, Ramsdale J: Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 2001; 8:305-310.
25. Kato J, Kuwabara Y, Mitani M: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 2001; 95:92-95.
26. Ikeguchi M, Ueda T, Sakatani T: Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol 2002; 11:33-40.
27. Chakravarti A, Noll E, Black PM: Quantitatively determined Survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 2002; 20:1063-1068.
28. Ikehara M, Oshita F, Kameda Y: Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small cell adenocarcinoma of the lung. Oncol Rep 2002; 9:835-838.
29. Deguchi M, Shiraki K, Inoue H: Expression of Survivin during liver regeneration. Biochem Biophys Res Commun 2002; 297(1):59.
30. Suzuki A, Shiraki K: Tumor cell "dead or alive": Caspase and Survivin regulate cell death, cell cycle and cell survival. Histol Histopathol 2001; 16(2):583-593.
31. Ikeguchi M, Ueta T, Yamane Y: Inducible nitric oxide synthase and surviving messenger RNA expression in hepatocellular carcinoma. Clin Cancer Res 2000; 8(10):3131-3136.
32. Shiraki K, Nakano T, Hisatomi H: Survivin in liver. Gastroenterology 2003; 124(5):1565-1566; author replay 1566-1567.
33. Marchetti A, Pellegrini C, Buttitta F: Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. Lab Invest 2002; 82:729-736.
34. Falleni M, Pellegrini C, Marchetti A: Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 2003; 200:620-626.
35. Nuciforo PG, Pellegrini C, Fasani R: Molecular and immunohistochemical analysis of HER2/neu in synovial sarcoma. Human Pathol 2003; 34:639-645.
36. Pellegrini C, Falleni M, Marchetti A: HER-2/neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time RT-PCR, fluorescence in situ hybridisation and immunohistochemistry. Clin Cancer Res 2003; 9:3645-3652.
37. Grossman D, McNiff JM, Li F: Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 1999; 79:1121-1126.
38. Sarela AI, Macadam RCA, Farmery SM: Expression of the antiapoptosis gene Survivin predicts death from recurrent colorectal carcinoma. Gut 2000; 46:645-650.